{"AllianceGenome": "20249", "HGNC": "20249", "MIM": "609291", "_id": "161742", "_version": 1, "accession": {"genomic": ["AC069381.8", "AL833561.1", "CH471125.1", "CP068263.2", "HF584361.1", "NC_000015.10", "NC_060939.1", "NG_008980.1"], "protein": ["AAH18015.1", "AAI37481.1", "AAI37482.1", "AAP59414.1", "BAC03614.1", "CCQ43858.1", "EAW92368.1", "NP_689807.1", "Q7Z699.2", "XP_005254259.1", "XP_047288155.1", "XP_047288156.1", "XP_047288157.1", "XP_054233356.1", "XP_054233357.1", "XP_054233358.1"], "rna": ["AK091222.1", "AK095219.1", "AY299089.1", "BC018015.1", "BC137480.1", "BC137481.1", "BX538234.1", "DA405650.1", "NM_152594.3", "XM_005254202.4", "XM_047432199.1", "XM_047432200.1", "XM_047432201.1", "XM_054377381.1", "XM_054377382.1", "XM_054377383.1"], "translation": [{"protein": "XP_054233357.1", "rna": "XM_054377382.1"}, {"protein": "AAI37482.1", "rna": "BC137481.1"}, {"protein": "BAC03614.1", "rna": "AK091222.1"}, {"protein": "XP_054233358.1", "rna": "XM_054377383.1"}, {"protein": "XP_047288157.1", "rna": "XM_047432201.1"}, {"protein": "AAI37481.1", "rna": "BC137480.1"}, {"protein": "XP_005254259.1", "rna": "XM_005254202.4"}, {"protein": "AAH18015.1", "rna": "BC018015.1"}, {"protein": "AAP59414.1", "rna": "AY299089.1"}, {"protein": "NP_689807.1", "rna": "NM_152594.3"}, {"protein": "XP_047288155.1", "rna": "XM_047432199.1"}, {"protein": "XP_047288156.1", "rna": "XM_047432200.1"}, {"protein": "XP_054233356.1", "rna": "XM_054377381.1"}]}, "alias": ["LGSS", "NFLS", "PPP1R147", "hSpred1", "spred-1"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2019-01-24T05:00:00.000Z", "disease_label": "Legius syndrome", "gcep": "RASopathy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0012669", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ba44430-8f71-4b94-a6f1-7f66d3a27897-2019-01-24T050000.000Z", "sop": "SOP6"}}, "ensembl": {"gene": "ENSG00000166068", "protein": ["ENSP00000299084", "ENSP00000453680"], "transcript": ["ENST00000299084", "ENST00000561205", "ENST00000561317"], "translation": [{"protein": "ENSP00000299084", "rna": "ENST00000299084"}, {"protein": "ENSP00000453680", "rna": "ENST00000561317"}], "type_of_gene": "protein_coding"}, "entrezgene": "161742", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 19.5519813203, "exp_mis": 144.597668311, "exp_syn": 54.5808809744, "lof_z": 3.70803864210417, "mis_z": 1.04120616737809, "mu_lof": 1.53368026778e-06, "mu_mis": 1.29818468207e-05, "mu_syn": 4.86480994999e-06, "n_lof": 3.0, "n_mis": 119.0, "n_syn": 49.0, "p_li": 0.868668326243136, "p_null": 1.54828635741044e-05, "p_rec": 0.13131619089329, "syn_z": 0.468308306122516}, "bp": 1335, "cds_end": 38643865, "cds_start": 38545386, "n_exons": 7, "nonpsych": {"exp_lof": 17.5677897975, "exp_mis": 130.746206638, "exp_syn": 49.272321341, "lof_z": 3.41339899704719, "mis_z": 1.22391332648895, "mu_lof": 1.53368026778e-06, "mu_mis": 1.29818468207e-05, "mu_syn": 4.86480994999e-06, "n_lof": 3.0, "n_mis": 103.0, "n_syn": 45.0, "p_li": 0.782894155979705, "p_null": 7.4535464439557e-05, "p_rec": 0.217031308555855, "syn_z": 0.383200243171939}, "nontcga": {"exp_lof": 17.975284713, "exp_mis": 133.017325435, "exp_syn": 50.2018708033, "lof_z": 3.71699459352579, "mis_z": 0.951087064876231, "mu_lof": 1.53368026778e-06, "mu_mis": 1.29818468207e-05, "mu_syn": 4.86480994999e-06, "n_lof": 2.0, "n_mis": 111.0, "n_syn": 44.0, "p_li": 0.952092788629421, "p_null": 5.73967383351509e-06, "p_rec": 0.0479014716967451, "syn_z": 0.554223595697142}, "transcript": "ENST00000299084.4"}, "exons": [{"cdsend": 38351664, "cdsstart": 38253185, "chr": "15", "position": [[38252835, 38253217], [38299372, 38299547], [38322240, 38322409], [38324762, 38324809], [38339736, 38339895], [38349421, 38349523], [38351013, 38357249]], "strand": 1, "transcript": "NM_152594", "txend": 38357249, "txstart": 38252835}], "exons_hg19": [{"cdsend": 38643865, "cdsstart": 38545386, "chr": "15", "position": [[38545036, 38545418], [38591573, 38591748], [38614441, 38614610], [38616963, 38617010], [38631937, 38632096], [38641622, 38641724], [38643214, 38649450]], "strand": 1, "transcript": "NM_152594", "txend": 38649450, "txstart": 38545036}], "generif": [{"pubmed": 15683364, "text": "We show here that Spred-1 and Spred-2 appear to have distinct mechanisms whereby they induce their effects, as the Sprouty domain of Spred-1 is not required to block MAPK (mitogen-activated protein kinase) activation, while that of Spred-2 is required."}, {"pubmed": 16652141, "text": "reduction of Spred expression in hepatocellular carcinoma (HCC) is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC"}, {"pubmed": 17672918, "text": "the apparent occurrence of an unusual TG 3' splice site in intron 1 is discussed"}, {"pubmed": 17704776, "text": "Studies show that the clinical features of the reported disorder resemble those of neurofibromatosis type 1 provide the first report of mutations of SPRED1 (SPROUTY)/SPRED family of genes) in human disease."}, {"pubmed": 18216281, "text": "enhanced TESK1 activity results in increased stress fibers (via phospho-cofilin), but this can be blocked by elevating Spred1"}, {"pubmed": 19120036, "text": "Linkage analysis of SPRED1 excluded its involvement in Cafe-au-lait spots in a patient with a severe form of Noonan syndrome."}, {"pubmed": 19366998, "text": "SPRED1 mutations occurred with a prevalence of 0.5% in NF1 patients and in 5% of NF1 patients displaying an NF1-like phenotype."}, {"pubmed": 19443465, "text": "Unrelated mild NF1 patients were screened for mutations of the SPRED1-3 and the SPRY1-4 genes. SPRED1 mutations were identified in 6 cases."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19920235, "text": "A high SPRED1 mutation detection rate was found in NF1 mutation-negative families with an autosomal dominant phenotype of CALMs (cafe au lait macules)with or without freckling and no other NF1 features."}, {"pubmed": 19920235, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20179001, "text": "The frequency of SPRED1 mutations in patients meeting diagnostic criteria for neurofibromatosis 1 in a hospital-based clinic is 1% to 2%. The likelihood an individual is harboring a SPRED1 mutation increases with age."}, {"pubmed": 20339110, "text": "no evidence of leukemogenic SPRED1 involement in juvenile myelomonocytic leukemia"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21364986, "text": "Sprouty and Spred proteins are negative regulators of the ERK/Elk-1 pathway activation induced not only by growth-factors, but also by reactive lipidic mediators."}, {"pubmed": 21531714, "text": "SPRED1 is a likely substrate of SHP2, whose tyrosine dephosphorylation is required to attenuate the inhibitory action of SPRED1 in the Ras/ERK pathway."}, {"pubmed": 21616146, "text": "Interaction of FGFRL1 with Spred1 increases the proportion of the receptor at the plasma membrane."}, {"pubmed": 21649642, "text": "a cohort of 115 NF1-like patients were screened for SPRED1 gene mutations and six mutations were identified. 12 potentially pathogenic SPRED1 mutations have been detected in 200 such NF1-like patients"}, {"pubmed": 22751498, "text": "show that neurofibromin, the NF1 gene product, is a Spred1-interacting protein that is necessary for Spred1's inhibitory function"}, {"pubmed": 22753041, "text": "Sixty-three mutations and deletions are definitely pathogenic or most likely pathogenic, eight SPRED1 mutations are probably benign rare variants, and 17 SPRED1 missense mutations are still unclassified. Review."}, {"pubmed": 23016555, "text": "Based on our current understanding of KIT and SPRED1 protein interactions, we propose that cafe-au-lait macules and freckling may be seen in some patients with piebaldism and does not necessarily represent coexistence of neurofibromatosis type 1."}, {"pubmed": 23811937, "text": "Data indicate that upregulated miR-126 upon coxsackievirus B3 (CVB3) infection targets SPRED1, LRP6, and WRCH1 genes, mediating cross-talk between ERK1/2 and Wnt/beta-catenin pathways, and thus promoting viral replication."}, {"pubmed": 23823658, "text": "Older age and deletions of IKZF1 and SPRED1 were also associated with poor overall survival of pediatric B-cell precursor acute lymphoblastic leukemia."}, {"pubmed": 24014835, "text": "Microrna-126 was transported into recipient human coronary artery endothelial cells by endothelial microparticles and functionally regulated the target protein sprouty-related, EVH1 domain-containing protein 1 (SPRED1)."}, {"pubmed": 24334617, "text": "SPRED1 seems to play an important role in recruiting neurofibromin to the plasma membrane. (Review)"}, {"pubmed": 24469042, "text": "SPRED1 decreased expression correlated with genetic features of AML. Our study reveals a new mechanism which contributes to deregulate RAS MAPK pathway in the vast majority of paediatric AMLs"}, {"pubmed": 25202123, "text": "Antisense-mediated knockdown (anti-miR) revealed that miR-206/21 coordinately promote RAS-ERK signaling and the corresponding cell phenotypes by inhibiting translation of the pathway suppressors RASA1 and SPRED1."}, {"pubmed": 25981987, "text": "This study constitutes the first report from Japan of Legius syndrome occurring in siblings. Mutation analysis showed a mutation of c.349C>T resulting in p.Arg117* in exon 4."}, {"pubmed": 26075267, "text": "Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer"}, {"pubmed": 26635368, "text": "Data suggest SPRED1 EVH1 domain interacts with NF1 GRD domain [N-term. 16AA/C-term. 20AA of GTPase-activating protein-related domain]; SPRED1 EVH1 and NF1 GRD mutations observed in Legius syndrome reduce binding affinity between EVH1/GRD domains."}, {"pubmed": 27203443, "text": "Results provide genetic evidence that miR-126, through its target gene Spred-1, plays a critical role in the development of retinal vascular layers."}, {"pubmed": 27313208, "text": "The EVH1 domain of Spred1 binds to the noncatalytic portion of the GAP-related domain of neurofibromin."}, {"pubmed": 27748283, "text": "PURA may be a potential target of miR-144 and observed downregulation of PURA may be caused by increased expression of miR-144. The other predicted target of miR-144 SPRED1, was found to be downregulated in 69 per cent EC tissues as compared to matched distant non-malignant tissues."}, {"pubmed": 28150585, "text": "In one case we identified a nonsense mutation c.46C>T (p.Arg16*) in exon 2 of SPRED1 gene, confirming diagnosis of Legius syndrome. This mutation was reported previously."}, {"pubmed": 29685157, "text": "SPRED1 is down-regulated by E2 and negatively correlated to ER status in BC cells. SPRED1 was a new direct target of miR-196a which participated in miR-196a-promoted BC development and was suppressed by ligand-activated ER-alpha signal pathway."}, {"pubmed": 30385465, "text": "this study establishes SPRED1 as a major tumor suppressor gene in mucosal melanoma."}, {"pubmed": 30745814, "text": "Aberrant methylation statuses of the SPRED1 promoter regions are associated with the downregulation of gene transcription in acute myeloid leukemia."}, {"pubmed": 31401120, "text": "These data provide structural insight into the interaction of Spred1 and neurofibromin."}, {"pubmed": 32575496, "text": "Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients."}, {"pubmed": 32773772, "text": "Constitutional mismatch repair deficiency is the diagnosis in 0.41% of pathogenic NF1/SPRED1 variant negative children suspected of sporadic neurofibromatosis type 1."}, {"pubmed": 33073945, "text": "A Study on the Expression of SPRED1 and PBRM1 (Baf180) and their Clinical Significances in Patients with Gastric Cancer."}, {"pubmed": 33078527, "text": "Moyamoya syndrome in a child with Legius syndrome: Introducing a cerebral vasculopathy to the SPRED1 phenotype?"}, {"pubmed": 33306107, "text": "SPRED1 deletion confers resistance to MAPK inhibition in melanoma."}, {"pubmed": 36629984, "text": "SPOCK2 and SPRED1 function downstream of EZH2 to impede the malignant progression of lung adenocarcinoma in vitro and in vivo."}, {"pubmed": 37434064, "text": "Long noncoding RNA LOC646029 functions as a ceRNA to suppress ovarian cancer progression through the miR-627-3p/SPRED1 axis."}], "genomic_pos": {"chr": "15", "end": 38357249, "ensemblgene": "ENSG00000166068", "start": 38252836, "strand": 1}, "genomic_pos_hg19": {"chr": "15", "end": 38649450, "start": 38544527, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0006469", "pubmed": 18216281, "qualifier": "involved_in", "term": "negative regulation of protein kinase activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010719", "qualifier": "involved_in", "term": "negative regulation of epithelial to mesenchymal transition"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010801", "pubmed": 20736167, "qualifier": "involved_in", "term": "negative regulation of peptidyl-threonine phosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0016525", "pubmed": 23136161, "qualifier": "involved_in", "term": "negative regulation of angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030512", "qualifier": "involved_in", "term": "negative regulation of transforming growth factor beta receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0043408", "pubmed": 18216281, "qualifier": "involved_in", "term": "regulation of MAPK cascade"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043409", "qualifier": "involved_in", "term": "negative regulation of MAPK cascade"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043409", "pubmed": 18694566, "qualifier": "involved_in", "term": "negative regulation of MAPK cascade"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043517", "pubmed": 20736167, "qualifier": "involved_in", "term": "positive regulation of DNA damage response, signal transduction by p53 class mediator"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060979", "pubmed": 23625462, "qualifier": "involved_in", "term": "vasculogenesis involved in coronary vascular morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0070373", "qualifier": "involved_in", "term": "negative regulation of ERK1 and ERK2 cascade"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0090051", "qualifier": "involved_in", "term": "negative regulation of cell migration involved in sprouting angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0090311", "pubmed": 20736167, "qualifier": "involved_in", "term": "regulation of protein deacetylation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1902747", "qualifier": "involved_in", "term": "negative regulation of lens fiber cell differentiation"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 18216281, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005901", "qualifier": "located_in", "term": "caveola"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0031410", "pubmed": 18216281, "qualifier": "colocalizes_with", "term": "cytoplasmic vesicle"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0005173", "qualifier": "enables", "term": "stem cell factor receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15231748, 19389623, 21900206, 22321011, 24705354, 26635368, 32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0019901", "qualifier": "enables", "term": "protein kinase binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019901", "pubmed": [18216281, 20736167], "qualifier": "enables", "term": "protein kinase binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0019902", "pubmed": 19389623, "qualifier": "enables", "term": "phosphatase binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0030291", "pubmed": 20736167, "qualifier": "enables", "term": "protein serine/threonine kinase inhibitor activity"}]}, "homologene": {"genes": [[7955, 406513], [8364, 493399], [9031, 423292], [9598, 467654], [9606, 161742], [9615, 487485], [9913, 519882], [10090, 114715], [10116, 296072]], "id": 24919}, "interpro": [{"desc": "WH1/EVH1 domain", "id": "IPR000697", "short_desc": "WH1/EVH1_dom"}, {"desc": "PH-like domain superfamily", "id": "IPR011993", "short_desc": "PH-like_dom_sf"}, {"desc": "SPRE, EVH1 domain", "id": "IPR041937", "short_desc": "SPRE_EVH1"}, {"desc": "Sprouty", "id": "IPR007875", "short_desc": "Sprouty"}, {"desc": "c-Kit-binding domain", "id": "IPR023337", "short_desc": "KBD"}], "ipi": "IPI00166291", "map_location": "15q14", "name": "sprouty related EVH1 domain containing 1", "other_names": ["protein phosphatase 1, regulatory subunit 147", "sprouty-related, EVH1 domain-containing protein 1", "suppressor of Ras/MAPK activation"], "pantherdb": {"HGNC": "20249", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2150016", "ortholog_type": "LDO", "panther_family": "PTHR11202", "taxid": 10090, "uniprot_kb": "Q924S8"}, {"RGD": "1308735", "ortholog_type": "LDO", "panther_family": "PTHR11202", "taxid": 10116, "uniprot_kb": "Q3C2P9"}, {"Ensembl": "ENSGALG00000028203", "ortholog_type": "LDO", "panther_family": "PTHR11202", "taxid": 9031, "uniprot_kb": "A0A3Q2TYY8"}, {"ZFIN": "ZDB-GENE-040426-2338", "ortholog_type": "LDO", "panther_family": "PTHR11202", "taxid": 7955, "uniprot_kb": "F1R8L9"}, {"FlyBase": "FBgn0020767", "ortholog_type": "LDO", "panther_family": "PTHR11202", "taxid": 7227, "uniprot_kb": "A0A0B4KG11"}, {"dictyBase": "DDB_G0289541", "ortholog_type": "O", "panther_family": "PTHR11202", "taxid": 352472, "uniprot_kb": "Q5TJ65"}], "uniprot_kb": "Q7Z699"}, "pathway": {"netpath": {"id": "Pathway_KitReceptor", "name": "KitReceptor"}, "pid": {"id": "kitpathway", "name": "Signaling events mediated by Stem cell factor receptor (c-Kit)"}, "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-190236", "name": "Signaling by FGFR"}, {"id": "R-HSA-5654736", "name": "Signaling by FGFR1"}, {"id": "R-HSA-5658442", "name": "Regulation of RAS by GAPs"}, {"id": "R-HSA-5658623", "name": "FGFRL1 modulation of FGFR1 signaling"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6802953", "name": "RAS signaling downstream of NF1 loss-of-function variants"}, {"id": "R-HSA-6802957", "name": "Oncogenic MAPK signaling"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}], "wikipathways": [{"id": "WP127", "name": "IL-5 signaling pathway"}, {"id": "WP2038", "name": "Regulation of Microtubule Cytoskeleton"}]}, "pdb": ["3SYX", "6V65", "6V6F"], "pfam": ["PF00568", "PF05210"], "pharmgkb": "PA134897382", "pharos": {"target_id": 13983, "tdl": "Tbio"}, "prosite": ["PS50229", "PS51227", "PS51488"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF174889", "relationship": "is"}, {"id": "GNF185795", "relationship": "is"}, {"id": "GNF196701", "relationship": "is"}, {"id": "GNF207607", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF040526", "relationship": "is"}, {"id": "GNF043007", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF100404", "relationship": "is"}, {"id": "GNF140059", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000015.10", "NC_060939.1", "NG_008980.1"], "protein": ["NP_689807.1", "XP_005254259.1", "XP_047288155.1", "XP_047288156.1", "XP_047288157.1", "XP_054233356.1", "XP_054233357.1", "XP_054233358.1"], "rna": ["NM_152594.3", "XM_005254202.4", "XM_047432199.1", "XM_047432200.1", "XM_047432201.1", "XM_054377381.1", "XM_054377382.1", "XM_054377383.1"], "translation": [{"protein": "XP_054233357.1", "rna": "XM_054377382.1"}, {"protein": "XP_054233358.1", "rna": "XM_054377383.1"}, {"protein": "XP_047288157.1", "rna": "XM_047432201.1"}, {"protein": "XP_005254259.1", "rna": "XM_005254202.4"}, {"protein": "NP_689807.1", "rna": "NM_152594.3"}, {"protein": "XP_047288155.1", "rna": "XM_047432199.1"}, {"protein": "XP_047288156.1", "rna": "XM_047432200.1"}, {"protein": "XP_054233356.1", "rna": "XM_054377381.1"}]}, "reporter": {"GNF1H": "gnf1h08537_at", "HG-U133_Plus_2": ["226837_at", "235074_at", "244439_at"], "HG-U95B": "48910_at", "HTA-2_0": "TC15000259.hg.1", "HuEx-1_0": ["3589141", "3707031"], "HuGene-1_1": "7982564", "HuGene-2_1": "16799231"}, "summary": "The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). [provided by RefSeq, Jul 2008].", "symbol": "SPRED1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1426807"}, "unigene": "Hs.525781", "uniprot": {"Swiss-Prot": "Q7Z699", "TrEMBL": "H0YMN8"}, "wikipedia": {"url_stub": "SPRED1"}}